Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Johannes Gutenberg-Universität Mainz

Saarstr. 21, 55099 Mainz
  • 6131/39-0
Publikationen
Ergebnisse pro Seite:  10

Wallis, Stuart; Wolska, Nina; Englert, Hanna et al.

A peptide from the staphylococcal protein Efb binds P-selectin and inhibits the interaction of platelets with leukocytes

JOURNAL OF THROMBOSIS AND HAEMOSTASIS. Bd. 20. H. 3. 2021 S. 729-741


Moehler, Markus; Michel, Maurice; Stein, Alexander et al.

A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancer

FUTURE ONCOLOGY. Bd. 17. H. 25. 2021 S. 3309-3319



Ebert, Anne-Karoline; Zwink, Nadine; Reutter, Heiko Martin et al.

A Prevalence Estimation of Exstrophy and Epispadias in Germany From Public Health Insurance Data

FRONTIERS IN PEDIATRICS. Bd. 9. 2021


Wierichs, R. J.; Kramer, E. J.; Reiss, B. et al.

A prospective, multi-center, practice-based cohort study on all-ceramic crowns

DENTAL MATERIALS. Bd. 37. H. 8. 2021 S. 1273-1282


Schmitz, Norbert; Truemper, Lorenz; Bouabdallah, Krimo et al.

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL

BLOOD. Bd. 137. H. 19. 2021 S. 2646-2656


Schattenberg, Jorn M.; Pares, Albert; Kowdley, Kris V. et al.

A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA

JOURNAL OF HEPATOLOGY. Bd. 74. H. 6. 2021 S. 1344-1354


Schuppan, Detlef; Maki, Markku; Lundin, Knut E. A. et al.

A randomized trial of a transglutaminase 2 inhibitor for celiac disease

NEW ENGLAND JOURNAL OF MEDICINE. Bd. 385. H. 1. 2021 S. 35-45


Goldbach, Nele; Reif, Andreas; Preuss, Hanna et al.

A Randomized Trial of Group Therapy for Resource Activation for Patients With Affective Disorder

JOURNAL OF PSYCHOTHERAPY INTEGRATION. 2021


Francque, Sven M.; Bedossa, Pierre; Ratziu, Vlad et al.

A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH

NEW ENGLAND JOURNAL OF MEDICINE. Bd. 385. H. 17. 2021 S. 1547-1558